New Delhi : India today logged 10,929 coronavirus cases, 14 per cent lower than yesterday (12,729). The country reported 392 deaths in the last 24 hours, the health ministry said.
The daily rise in new coronavirus infections has been below 20,000 for 29 straight days and less than 50,000 daily new cases have been reported for 132 consecutive days now.
The daily positivity rate was recorded at 1.35 per cent. It has been less than two per cent for last 33 days. The weekly positivity rate was also recorded at 1.27 per cent. It has been below two per cent for the last 42 days, according to the ministry.
The number of active cases came down to 1,46,950 from 1,48,922 on Friday, the data updated at 8 am showed.
The cumulative doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 107.92 crore.
The active cases comprise 0.43 per cent of the total infections, the lowest since March last year. The national recovery rate stands at 98.23 per cent, the highest since March last year, the ministry said.
This week, the World Health Organization granted Covaxin an Emergency Use Listing, which means the ‘made-in-India’ vaccine will finally be recognised by other countries and Indians who received the shot need not self-quarantine or face restrictions when travelling abroad.
The United States has also given a green signal to the entry of people vaccinated with India-made Covaxin.
On Friday, Pfizer Inc said that its experimental antiviral pill for COVID-19 cuts by 89% the chances of hospitalization or death for adults at risk of developing severe disease.
India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.
India’s caseload crossed the grim milestone of two crore on May 4 and three crore on June 23.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
